Investor profile
Ysios Capital has backed 20 European tech companies across 24 funding rounds between 2009 and 2026, joining rounds totalling €948M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| SpliceBio | Spain | 2 | €168M |
| Galecto Biotech | Denmark | 1 | €79M |
| Sparingvision | France | 1 | €75M |
| Ona Therapeutics | Spain | 1 | €74M |
| Northsea Therapeutics | Netherlands |
| Company | Stage | Amount | Date |
|---|---|---|---|
| SpliceBio | Series B | €118M | 2025-06 |
| Galecto Biotech | Series C | €79M | 2018-10 |
| Sparingvision | Series B | €75M | 2022-09 |
| Ona Therapeutics |
| 1 |
| €71M |
| Minoryx Therapeutics | Spain | 2 | €70M |
| ReproNovo | Switzerland | 1 | €57M |
| Endosense | Switzerland | 2 | €56M |
| Xeltis | Switzerland | 1 | €45M |
| Vivet Therapeutics | France | 1 | €38M |
| Sanifit | Spain | 1 | €37M |
| Medlumics | Spain | 1 | €34M |
| OxThera | Sweden | 1 | €32M |
| STAT-Diagnostica | Spain | 2 | €27M |
| Memo Therapeutics | Switzerland | 1 | €20M |
| BioVex | UK | 1 | €20M |
| Corwave | France | 1 | €16M |
| Anaconda Biomed | Spain | 1 | €15M |
| AM-Pharma | Netherlands | 1 | €12M |
| Inbiomotion | Spain | 1 | €2.1M |
| Series B |
| €74M |
| 2026-06 |
| Northsea Therapeutics | Other | €71M | 2021-12 |
| ReproNovo | Series A | €57M | 2025-05 |
| Minoryx Therapeutics | Series C | €51M | 2022-05 |
| SpliceBio | Series A | €50M | 2022-02 |
| Xeltis | Series C | €45M | 2017-04 |
| Vivet Therapeutics | Series A | €38M | 2017-05 |
